Paliperidone Palmitate
Paliperidone Palmitate is an active ingredient in 17 FDA-listed drug products sold under 4 names.
Drugs containing Paliperidone Palmitate
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 72526-110 | Erzofri extended-release Injection | 351 mg/2.25mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 72526-106 | Erzofri extended-release Injection | 78 mg/.5mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 72526-107 | Erzofri extended-release Injection | 117 mg/.75mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 72526-108 | Erzofri extended-release Injection | 156 mg/mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 72526-109 | Erzofri extended-release Injection | 234 mg/1.5mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 72526-105 | Erzofri extended-release Injection | 39 mg/.25mL | Shandong Luye Pharmaceutical Co., Ltd. |
| 50458-612 | Invega Hafyera Injection, Suspension, Extended Release | 1560 mg/5mL | Janssen Pharmaceuticals, Inc |
| 50458-611 | Invega Hafyera Injection, Suspension, Extended Release | 1092 mg/3.5mL | Janssen Pharmaceuticals, Inc |
| 50458-561 | Invega Sustenna Injection | 78 mg/.5mL | Janssen Pharmaceuticals, Inc. |
| 50458-563 | Invega Sustenna Injection | 156 mg/mL | Janssen Pharmaceuticals, Inc. |
| 50458-560 | Invega Sustenna Injection | 39 mg/.25mL | Janssen Pharmaceuticals, Inc. |
| 50458-564 | Invega Sustenna Injection | 234 mg/1.5mL | Janssen Pharmaceuticals, Inc. |
| 50458-562 | Invega Sustenna Injection | 117 mg/.75mL | Janssen Pharmaceuticals, Inc. |
| 50458-608 | Invega Trinza Injection, Suspension, Extended Release | 546 mg/1.75mL | Janssen Pharmaceuticals, Inc |
| 50458-609 | Invega Trinza Injection, Suspension, Extended Release | 819 mg/2.63mL | Janssen Pharmaceuticals, Inc |
| 50458-607 | Invega Trinza Injection, Suspension, Extended Release | 410 mg/1.32mL | Janssen Pharmaceuticals, Inc |
| 50458-606 | Invega Trinza Injection, Suspension, Extended Release | 273 mg/.88mL | Janssen Pharmaceuticals, Inc |